To further confirm our hypothesis, we performed microarray, bioinformatics, and Western blotting assays to indicate whether GINS2 affects the ERK pathway to alter the biological behaviors of pancreatic cancer cell lines. This evidence concerns the gene GINS2 and pancreatic neoplasm.